Breast Lobular Carcinoma In Situ
generalA condition in which abnormal cells are found in the lobules of the breast. Lobular carcinoma in situ seldom becomes invasive cancer; however, having it in one breast increases the risk of developing breast cancer in either breast.
11
Centers
14
Active Trials
—
Cancer Funding
Specific Cancer Types(1)
| Name | Centers |
|---|---|
| Breast Pleomorphic Lobular Carcinoma In Situ | — |
Top Centers for Breast Lobular Carcinoma In Situ(11)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive High-Volume Research Center | 75.0 |
| 2 | University of Michigan Rogel Cancer CenterAnn Arbor, MI NCI Comprehensive Active Research Program | 68.9 |
| 3 | University of Illinois Cancer CenterChicago, IL Active Research Program | 68.9 |
| 4 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 50.5 |
| 5 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program | 50.5 |
| 6 | City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive Active Research Program | 50.5 |
| 7 | Cedars-Sinai CancerLos Angeles, CA Active Research Program | 50.5 |
| 8 | Cleveland Clinic Cancer CenterCleveland, OH Active Research Program | 50.5 |
| 9 | Boston University Cancer CenterBoston, MA Active Research Program | 50.5 |
| 10 | Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL Active Research Program | 50.5 |
| 11 | Cancer Center at IllinoisUrbana, IL | 34.1 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →